Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Imlifidase

EU orphan designation number: EU/3/18/2096   
Active ingredient: Imlifidase
Indication: Treatment of anti-glomerular basement membrane disease
Sponsor: Hansa Biopharma AB
Scheelevägen 22, P.O. Box 785, 220 07 Lund, Sverige

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2018 Orphan designation EMA/OD/093/18 (2018)7806 of 19/11/2018
4/02/2019 Change of name and/or address of sponsor